CME Group/$CME
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About CME Group
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
- Ticker
- $CME
- Sector
- Finance
- Primary listing
- NASDAQ
- Employees
- 3,875
- Headquarters
- Chicago, United States
- Website
- www.cmegroup.com
CME Group Metrics
BasicAdvanced
$109B
24.86
$12.19
0.27
$11.30
1.72%
Price and volume
Market cap
$109B
Beta
0.27
52-week high
$329.16
52-week low
$218.31
Average daily volume
2M
Dividend rate
$11.30
Financial strength
Current ratio
1.019
Quick ratio
0.02
Long term debt to equity
0.129
Total debt to equity
0.145
Dividend payout ratio (TTM)
92.52%
Interest coverage (TTM)
26.42%
Profitability
EBITDA (TTM)
4,942.4
Gross margin (TTM)
100.00%
Net profit margin (TTM)
63.48%
Operating margin (TTM)
66.24%
Effective tax rate (TTM)
23.49%
Revenue per employee (TTM)
$1,800,000
Management effectiveness
Return on assets (TTM)
1.52%
Return on equity (TTM)
16.13%
Valuation
Price to earnings (TTM)
24.858
Price to revenue (TTM)
15.657
Price to book
4.09
Price to tangible book (TTM)
-30.43
Price to free cash flow (TTM)
25.144
Free cash flow yield (TTM)
3.98%
Free cash flow per share (TTM)
12.056
Dividend yield (TTM)
3.73%
Forward dividend yield
1.72%
Growth
Revenue change (TTM)
8.94%
Earnings per share change (TTM)
18.17%
3-year revenue growth (CAGR)
9.23%
10-year revenue growth (CAGR)
7.13%
3-year earnings per share growth (CAGR)
13.32%
10-year earnings per share growth (CAGR)
11.01%
3-year dividend per share growth (CAGR)
6.20%
10-year dividend per share growth (CAGR)
8.39%
What the Analysts think about CME Group
Analyst ratings (Buy, Hold, Sell) for CME Group stock.
Analyst projections of the future price of CME Group stock.
Bulls say / Bears say
CME’s third-quarter average daily volume rose 16% year on year to a record 29.4 million contracts, lifting revenue 13% to a third-quarter record and adjusted earnings per share 13%. Double-digit volume growth across all six asset classes shows broad demand for its markets. (CME Group)
Market-data revenue reached a record $243 million in the third quarter, up 20%, and marked a 34th consecutive quarter of year-on-year growth. This growing revenue stream could help diversify earnings beyond trading fees. (CME Group)
CME plans to start its Treasury cash and repo clearing service on 7 December, subject to regulatory approval, as new US rules require central clearing of eligible transactions. Its cross-margining with futures could attract clients seeking to lower the capital tied up in trading. (CME Group)
The average fee earned per futures and options contract fell to $0.679 in the third quarter from $0.702 a year earlier. A less favourable product or customer mix could therefore limit how much revenue growth CME gets from rising volumes. (CME Group)
Second-quarter operating income fell 2% year on year despite slightly higher revenue, as technology and licensing costs rose. Continued cost pressure, including during the cloud transition, could weigh on margins if revenue growth slows. (Yahoo Finance)
Newly approved perpetual futures could compete with traditional listed derivatives, and CME has challenged their regulatory treatment in court. The CFTC has asked the court to dismiss CME’s case, leaving the competitive and legal outcome uncertain. (The Block)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.
CME Group Financial Performance
Revenues and expenses
CME Group Earnings Performance
Company profitability
Upcoming events
No upcoming events
CME Group News
AllArticlesVideos
Funds containing CME Group
AllUSDEURGBP
Fund name | Fund size | $CME weighting |
|---|---|---|
Invesco CoinShares Global Blockchain£BCHS | $976M | 2.88% |
iShares S&P 500 Financials Sector$IUFS | $2.5B | 1.33% |
iShares S&P 500 Financials Sector£UIFS | $2.4B | 1.33% |
Invesco S&P US Select Sector Financials£XLFQ | $396M | 1.30% |
Invesco Financials S&P US Select Sector$XLFS | $396M | 1.30% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.